An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer

Daniel Morgensztern, Pilar Garrido, Olga Burdaeva et al.|Lung Cancer|2019

Cited by 24